---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000800034.md"
description: "📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $Tempus AI(TEM.US) Tempus Study Shows AI Improves Prostate Cancer Diagnosis and Lab Efficiency👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:➤  𝐀𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐭𝐞 𝐏𝐫𝐨 study results published in 𝐍𝐚𝐭𝐮𝐫𝐞 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞.➤  𝐏𝐚𝐢𝐠𝐞 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 assisted pathologists in updating diagnoses for 𝐒% of patients.➤  𝐈.𝟑% of AI-assisted changes could potentially alter clinical management.➤  Study evaluated biopsies from more than 𝐈,𝟎𝟎𝟎 patients across three UK NHS trusts.➤  AI improved 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 consistency by detecting subtle cancer lesions.➤  Laboratories reported results delivered nearly 𝐨𝐧𝐞 𝐝𝐚𝐲 sooner.➤  AI reduced requests for additional 𝐢𝐦𝐦𝐮𝐧𝐨𝐡𝐢𝐬𝐭𝐨𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 (𝐈𝐇𝐂) staining.➤  Findings indicate improved 𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 efficiency and resource utilization.➤  Paige Prostate Suite is part of the 𝐓𝐞𝐦𝐩𝐮𝐬 intelligent diagnostics ecosystem.👉 𝐄𝐱𝐩𝐞𝐫𝐭 𝐒𝐭𝐚𝐭𝐞𝐦𝐞𝐧𝐭:𝐑𝐚𝐳𝐢𝐤 𝐘𝐨𝐮𝐬𝐟𝐢, Senior Vice President and General Manager of AI Products at Tempus:&#34;The rigorous, real-world results in the Articulate Pro study are a massive step forward for the global adoption of digital pathology. Integration of the Paige Prostate Suite directly into routine workflows shows that AI doesn't just work in a sandbox; it can actively alleviate the immense pressure on overstretched laboratories, cut down reporting times and give pathologists an extra layer of confidence when making critical diagnostic decisions.&#34;"
datetime: "2026-07-16T12:35:54.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000800034.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000800034.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000800034.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# 📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $Tempus AI(TEM.US) Tempus Study Shows A…


### Related Stocks

- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**